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The oxidative phosphorylation system is one of the
best-characterized metabolic pathways. In mam-
mals, the protein components and X-ray structures
are defined for all complexes except complex I.
Here, we show that NDUFA4, formerly considered a
constituent of NADH Dehydrogenase (CI), is instead
a component of the cytochrome c oxidase (CIV).
Deletion of NDUFA4 does not perturb CI. Rather, pro-
teomic, genetic, evolutionary, and biochemical anal-
yses reveal that NDUFA4 plays a role in CIV function
and biogenesis. The change in the attribution of the
NDUFA4 protein requires renaming of the gene and
reconsideration of the structure of CIV. Furthermore,
NDUFA4 should be considered a candidate gene for
CIV rather than CI deficiencies in humans.
INTRODUCTION
The OXPHOS system is one of the better and more deeply char-
acterized metabolic pathways (Saraste, 1999). It is composed of
four respiratory complexes, called complex I (NADH-ubiquinone
oxidoreductase), complex II (succinate:ubiquinone oxidoreduc-
tase), complex III (ubiquinol-cytochrome c reductase), and
complex IV (cytochrome c oxidase); the electron carriers ubiqui-
none (UQ or CoQ) and cytochrome c (cyt c); and the H+-ATP syn-
thase (complex V). All the structural protein components of the
mammalian OXPHOS system are thought to be known. Complex
I is composed of 45 subunits, complex II of 4, complex III of 11,
complex IV of 13, and complex V of 11 proteins. In addition,
a large number of assembly factors continue to be described
for all the complexes, and research into assembly pathways
remains a highly active field (for review, see Ferna´ndez-Vizarra
et al., 2009). The biochemical organization of the complexes is
also well characterized, but several key issues remain to be
deciphered: the organization of cofactors in CI is not yet fully
solved (Roessler et al., 2010), the interaction of this complex
with CoQ is not well established (Ohnishi et al., 2005; Shin-
zawa-Itoh et al., 2010), and the proton translocation mecha-
nisms in CI and IV have not been fully determined (Xu and378 Cell Metabolism 16, 378–386, September 5, 2012 ª2012 ElsevieVoth, 2008). The X-ray structures of complex II (Sun et al.,
2005), III (Iwata et al., 1998), and IV (Tsukihara et al., 1995,
1996) have been solved, as well as that of the F1 domain and
the membrane-extrinsic region of complex V (Abrahams et al.,
1994; Rees et al., 2009) and the complex I structure of E. coli
(Efremov et al., 2010; Efremov and Sazanov, 2011) and Yarrowia
mitochondria (Hunte et al., 2010). However, the X-ray structures
of complex I in higher eukaryotes and of FO domain of ATP syn-
thase remain unsolved (Ferna´ndez-Vizarra et al., 2009).
This formidable accumulation of information about the
OXPHOS system has turned out to be insufficient to explain
the phenotypic consequences of its dysfunction, and we are
consequently confronted by an impressive lack of understanding
about why, where, how, and when disease will manifest if the
OXPHOS system is impaired. Moreover, research into specific
diseases has revealed major shortcomings in the established
models of electron transport chain organization (Acı´n-Pe´rez
et al., 2004). Investigation of human OXPHOS diseases teaches
us that our basic knowledge of the system is far from complete
and that a description of the component elements, albeit
exhaustive, does not provide a functional understanding of
the system as a whole. Here, we demonstrate that even aspects
that were considered to be fully established, such as the
number and subunit composition of the respiratory complexes,
need to be revised: we provide compelling evidence that
NDUFA4, a protein considered to be a complex I structural
subunit (Carroll et al., 2006), is in fact an essential structural
protein of complex IV.
RESULTS
Different Comigrating Pattern of NDUFA4 in Blue
Native Gels
To identify interactions between mitochondrial proteins that may
be revealed by their comigration on native gels, we are imple-
menting a systematic proteomic analysis of mitochondrial
protein bands in blue-native gels (Figures 1A and 1B). Thus,
we compared wild-type mouse cell lines with cells from mutants
with specific loss of individual respiratory complexes (CIKO,
CIIIKO, or CIVKO) or lacking mtDNA (r-cells). To maximally
preserve in vivo protein interactions, we solubilized mitochon-
drial membranes with digitonin (Acı´n-Pe´rez et al., 2008).
Since the protein composition of the mammalian respiratoryr Inc.
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Iwata et al., 1998; Tsukihara et al., 1996), we examined them
to determine the robustness of our approach and the level of
sensitivity for highly hydrophobic mitochondrial inner membrane
proteins. Our system detected 39 of the 45 CI proteins (Carroll
et al., 2006; Hirst et al., 2003), 3 of the 4 CII proteins (Cecchini,
2003), 10 of the 11 CIII proteins (Iwata et al., 1998), and 8 of
the 13 CIV proteins (Tsukihara et al., 1996) (Figure 1A). Our anal-
ysis also confirmed the comigration of complexes when assem-
bled into different supercomplexes (I2+III2; I+III2+IVn; I+III2; and
III2+ IV). Most of the proteins showed the expected distribution
pattern on the BN gel, and knockout of one complex subunit
not only almost abolished the detection of proteins of the same
complex, but also deleted components of other complexes
that associate in the same supercomplex (Figure 1A). Notably,
although CI is degraded in the absence of CIII or IV, expression
of CI proteins was better preserved in CIIIKO cells, suggesting
that CI is more unstable in the absence of CIV than in the
absence of CIII (Figure 1A).
In departure from the expected behavior, we found NDUFA4
(unequivocally identified by three specific peptides; Figure S1),
classically described as a CI subunit (Carroll et al., 2003; Hirst
et al., 2003), in a distribution pattern consistent with components
of CIV (Figure 1A). In control cells, NDUFA4 never occurred in
positions where CI migrates alone; on the contrary, it always
comigrated with CIV subunits, either at positions where CIV
migrates alone, or assembled in supercomplex I+III2+IVn. More-
over, in CIKO samples, where only four of the CI subunits are
detected (NDUFS7, NDUFS3, NDUFA8, and ND1—comigrating
in a previously described subcomplex [Vogel et al., 2007]),
NDUFA4 was still present and comigrated with CIV. In contrast,
in CIVKO cells, NDUFA4 was deleted, together with all CIV
proteins (Figure 1A). Moreover, in CIIIKO cells, almost all CI
subunits are detected as individual CI; but NDUFA4 again comi-
grated with CIV subunits. This proteomic analysis shows that
NDUFA4 behaves like a CIV protein.
NDUFA4 Interacts with Proteins of Complex IV
To validate the proteomic analysis, we conducted immunopre-
cipitation experiments to determine whether NDUFA4 interacts
directly with CIV. Endogenous NDUFA4 was specifically precip-
itated by antibodies targeting CIV subunits, but not by antibodies
targeting CI (Figure 1C). Specific immunodetection analysis also
confirmed comigration of NDUFA4 with CIV (Figure 1D), and
resolving two-dimension gels showed NDUFA4 comigrating
with CIV subunits (Figure 1E). Furthermore, in mouse cells lack-
ing either ND4 or ND6, which showed a complete absence of CI
when tested for several canonical proteins for this complex,
NDUFA4 remained at the position of CIV (Figure 2A). In contrast,
in mouse cells lacking COX10 (COX10KO), which cannot fully
assemble CIV, NDUFA4 comigrated with an immature form of
CIV, and in human cells lacking COX2 (COX2KO), which are
similarly unable to form CIV, NDUFA4 was completely absent
(Figure 2B). These results strongly indicate that NDUFA4 is
a subunit of CIV and not CI. Furthermore, we notice that, contrary
to what was found for mouse cultured cells (Diaz et al., 2006),
human cells lacking CIV (see Figure S2 for a characterization of
the Cox2KO cells) are still able to retain a significant amount of
assembled CI (Figure 2C) that mainly interact with CIII. In theseCell Mecells complex NDUFA4 is not detected. To ensure that CI was
fully active despite the absence of NDUFA4 and CIV, we per-
formed in-gel activity for NADH dehydrogenase (CI) or for CIV.
Complex IV activity was detected in both wild-type and 80%
mutant Cox2 cells, but not in 100% mutant Cox2 ones (Fig-
ure 2D). However, in-gel CI activity is easily appreciated in all
tested cell lines regardless of whether they have CIV or not (Fig-
ure 2D). To determine if this NADH dehydrogenase activity was
reflecting a true functional CI in vivo, we transformed Cox2KO
cells with AOX (an alternative electron transport system present
in lower eukaryotes, plants, and lower animals that can perform
the overall oxidation of CoQH2, instead of CIII and CIV, which are
able to work in mammalian cells [Perales-Clemente et al., 2008]).
The expression of AOX does not modify qualitatively the pres-
ence of CI or its in-gel activity detection (Figures 2C and 2D). It
allows Cox2KO to respire to a robust rate and, this respiration
being substantially sensitive to rotenone, a CI-specific inhibitor
(Figure 2E). This demonstrates that NDUFA4 is not required to
form a fully functional CI.
Targeting NDUFA4 Protein Disrupts Normal Levels
of Complex IV
If NDUFA4 is a genuine CIV subunit, its downregulation is likely to
affect CIV activity. To test this, we stably silenced NDUFA4 in
HeLa cells and monitored the activity and stability of CI and
CIV. Upon downregulation of NDUFA4, CIV levels were reduced,
whereas CI and CIII showed no obvious change (Figure 3A).
Two-dimensional western blot also revealed reduced levels of
CIV, although no preassembled complexes were detected (Fig-
ure 3B). To confirm that the phenotype induced by NDUFA4
silencing was entirely due to the reduced expression of this
protein, we performed rescue experiments, in which myc-
tagged NDUFA4 was overexpressed in stably NDUFA4 inter-
fered cells. To allow myc-NDUFA4 expression, the locus for
the endogenous NDUFA4 interference was removed in the
myc-NDUFA4. Exogenous NDUFA4 fully restored CIV levels
(Figure 3C), confirming the role of these proteins in cytochrome
c oxidase maintenance and function.
The protein expression changes were paralleled by changes in
CIV activity, with a decrease in activity observed in shNDUFA4
HeLa cells (Figure 3D) that was restored by overexpression of
myc-NDUFA4. These changes were not accompanied by signif-
icant alterations in CI activity (not shown). Culture in galactose
medium, which forces cells to rely on OXPHOS-dependent
generation of ATP, demonstrated that the reduced CIV activity
in NDUFA4-interfered cells inhibited proliferation compared
with nonsilenced counterparts (Figure 3E).
The Evolution of NDUFA4 Correlated with That
of Complex IV
Previous evolutionary analyses of NDUFA4 indicated its pres-
ence outside vertebrate evolutionary clade (Gabaldo´n et al.,
2005), and more recently outside metazoa (Huynen et al.,
2009), yet NDUFA4 has not been confirmed to be a genuine
complex I subunit in fungi or plants (Cardol, 2011). Due to high
sequence divergence rates to identify NDUFA4 homologs in
eukaryotic species, we used hidden Markov models, similar to
approaches employed to establish new COX assembly factors
(Szklarczyk et al., 2012). Using sensitive homology searches,tabolism 16, 378–386, September 5, 2012 ª2012 Elsevier Inc. 379
Figure 1. The NDUFA4 Protein Behaves as a Structural Component of Complex IV
(A) Scheme of retrieved peptides from MS/MS analysis of the gel slices cut from the gel shown in (B) (numbers under the graphic correspond to the gel slice
number indicated in B). The position of the free complexes or supercomplexes is indicated on top for each line run on gel B and labeled as the indicated control or
mutant cell line. In the scheme can be followed the distinct behavior of mitochondrial electron transport complex proteins (indicated at the right side, NDUFA4 is
highlighted). Different colors identify components of individual complexes (complex I, blue; complex II, pink; complex III, yellow; complex IV, orange; NDUFA4 is
shown in red).
(B) Representative Coomassie-stained blue native gel from which the bands were excised for the proteomic analysis summarized in (A). The gel was loaded with
extracts fromwild-type cells and cell lines depleted for specificmitochondrial electron transport complexes: control, wild-type cells; CIKO, cells lacking complex I;
CIIIKO, cells lacking complex III; CIVKO, cells lacking complex IV; r, mtDNA-less cells lacking complexes I, III, and IV.
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NDUFA4 Is a Complex IV Structural Subunitwe discovered that NDUFA4 homologs’ presence-absence
patterns are not congruent with evolution of complex I as previ-
ously thought. Analysis of NDUFA4 presence-absence patterns
in fungi (Figure 4A) reveals the existence of the NDUFA4 gene in
all OXPHOS-encoding species. We identified NDUFA4 in
Saccharomyces cerevisiae and other Saccharomycetaceae
that have lost CI (Figure 4A). The yeast’s protein, encoded by
a gene of unknown function, YPR010C-A, shares common
features with the human NDUFA4, such as short length (81
amino acids in human and 72 in yeast) and the N-terminal trans-
membrane region (Figure 4B). While little is known about the
gene’s function in yeast, the protein has recently been copuri-
fied together with supercomplex III/IV from digitonin-solubilized
mitochondria (Vukotic et al., 2012). The YPR010C-A protein
sequence in S. cerevisiae is not divergent from CI-containing
NDUFA4 in a related fungus, Debaryomyces hansenii, indicating
that the CI loss in the ancestor of yeast did not significantly
alter the rate of sequence evolution of the gene. A high
sequence divergence due to a relaxed evolutionary pressure
would be expected if the gene’s primary role in fungi related
to CI. Also in the fission yeast Schizosaccharomyces pombe,
species that lost CI independently from the budding yeast
(Figure 4A), we identify the NDUFA4 homolog encoded by
SPBC3H7.08c gene (Figure 4B). Outside fungi, the gene can
be found in CI-lacking apicomplexans, including the malaria
parasite Plasmodium falciparum (Figure 4B). Worth noting is
the loss of NDUFA4 in Blastocystis hominis, a species that
encodes CI in its genome, but lacks complexes III, IV, and V.
Taken together, the analysis of NDUFA4 gene evolution argues
against the gene’s involvement in CI and supports the protein’s
role in CIV function.DISCUSSION
Our findings are in clear conflict with the published crystal struc-
tures for cytochrome c oxidase. These revealed 13 distinct
protein subunits, five phosphatidyl ethanolamines, three phos-
phatidyl glycerols and two cholates, two heme A molecules,
three copper II ions, one magnesium ion, and one zinc ion, but
no trace of NDUFA4. We hypothesized that NDUFA4 subunit
might be lost during the purification of CIV in order to generate
crystals. To obtain a high-quality crystal, samples are stringently
purified using a wide range of detergents. One of the standard
detergents used to purify CIV for crystallization purposes is
n-dodecyl b-D-maltoside (DDM). We found that concentrations
of DDM above 1.5% disrupt the interaction of NDUFA4 with
CIV without affecting the remaining proteins (Figure S3). We
therefore propose that this is the underlying cause for the failure
of crystallization studies to detect NDUFA4 in CIV.
NDUFA4was originally cataloged byWalker and coworkers as
an accessory subunit of themitochondrial membrane respiratory
chain NADH dehydrogenase, or CI (Carroll et al., 2002, 2003,
2006; Hirst et al., 2003); however, the authors found several(C) Isolated mitochondria from HeLa cells were solubilized with 1% DDM and im
NDUFA4 both coimmunoprecipitate with CIV, whereas NDUFB6 coimmunoprec
(D and E) Isolated mitochondria from HeLa cells were digitonized and resolved b
SDS-PAGE (E). After electrophoresis, membranes were probed with antibodies s
Cell Mecontradictory lines of evidence that made them doubt whether
NDUFA4 was a genuine CI subunit (Hirst et al., 2003). In fact,
NDUFA4 was not detected in all CI preparations and, more
importantly, its presence correlated with contamination by the
cytochrome c oxidase subunit VIB (Hirst et al., 2003). It may
therefore be that the absence of NDUFA4 from CI preparations
depends on detergent-mediated removal of cardiolipin, as
occurs with other cytochrome c oxidase components, such as
subunit VIB (Sedla´k and Robinson, 1999). It is likely that, despite
these warning signs, the established subunit composition of the
other respiratory complexes based on their crystallization led to
the acceptance of NDUFA4 as a CI subunit (Hirst et al., 2003).
More recent evidence indicates that the expression pattern of
NDUFA4 diverges notably from other CI nDNA-encoded
subunits, leading to speculation that NDUFA4 may have other
roles in addition to being a subunit of CI (Garbian et al., 2010).
The full significance of these doubts and discrepancies is
made clear in the light of our observations.
The change in the assignation of NDUFA4 from CI to CIV has
important and wide implications. First, it may require redefinition
of the structure of CIV. Second, it may now be necessary to
consider NDUFA4 as a candidate gene for CIV deficiencies in
humans, rather than for CI deficiencies. And third, it calls the
attention to protocols for protein crystallization, especially from
membrane protein complexes, because some proteins can be
washed out during the multistep detergent-based purification
of the crystals.
EXPERIMENTAL PROCEDURES
Cell Lines and Media
Mouse fibroblasts (wild-type, COX10KO, ND4KO, and ND6KO), human fibro-
blasts (wild-type and COX2KO), and HeLa cells were cultured in DMEM
containing 10%heat-inactivated fetal bovine serum (FBS). All media were sup-
plemented with 100 IU/ml penicillin and 100 mg/ml streptomycin. COX10KO
and COX2KO fibroblasts were also supplemented with 50 mg/ml uridine.
MtDNA-less mouse cells (rL929) were grown in DMEM supplemented with
5% FBS, 50 mg/ml uridine, and 1 mM pyruvate (r medium) and in the pres-
ence of 250 mg/ml of geneticin (G418). Medium for cells stably knocked
down for NDUFA4 was supplemented with 1 mg/ml puromycin. Cells were
maintained in 5% CO2/95% air at 37
C.
shRNA and Expression Vectors
HeLa cells were stably transfected with one of two shRNA targeting sequences
for NDUFA4 (sh.38 and sh.41). Specific lentivirus particles were purchased
from Dharmacon. Empty vector or PCMV containing the NDUFA4 open
reading frame were from OriGene and were used to transfect control HeLa
cells and cells knocked down with sh.38 and sh.41 shRNAs.
Isolation of Mitochondria
Mitochondria were isolated from cultured cell lines according to Ferna´ndez-
Vizarra et al., 2002, with some modifications. The following detergents were
used for extracting mitochondrial membrane proteins: n-dodecyl b-D-malto-
side (DDM) at 0.5%, 1%, or 3%; digitonin (DIG) at 4 g/g.
Blue Native Gel Electrophoresis and Western Blot Analysis
Mitochondrial membrane proteins (100–150 mg) were applied and run on
3%–13% first-dimension gradient BN gels as described elsewheremunoprecipitated with specific antibodies against either CIV or CI. COI and
ipitates with CI exclusively.
y one-dimensional BNGE (D) or by BNGE followed by a second dimension of
pecific for CI (NDUFB6 and NDUFS5), CIII (Core II), CIV (COI), and NDUFA4.
tabolism 16, 378–386, September 5, 2012 ª2012 Elsevier Inc. 381
Figure 2. BNGE Analysis in Mutant Fibroblast Lines Lacking Either Complex IV or Complex I
(A) CI depleted cells: mouse fibroblasts lacking ND4 and ND6.
(B) CIV depleted cells: mouse fibroblasts lacking COX10 and human fibroblasts lacking COX2.
(C) Human cells lacking COX2 and expressing or not AOX or with 80% of the mutant Cox2 gene probed against complex I (NDUFV1, NDUFA9), complex III
(Core2), complex II (SDHA), and NDUFA4. Western blots were probed with antibodies against the proteins indicated beneath the blots in (A)–(C).
(D) In-gel activity of a paralleled run gels to that of (C) above.
(E) Box plot showing oxygen consumption by the indicated intact cells under coupled or uncoupled conditions (by CCCP) and effect of CI activity inhibition by
rotenone. Box plot represents data distribution by different quartile.
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Figure 3. Complex IV Is Impaired in the Absence of NDUFA4
(A–D) NDUFA4 was stably knocked down in HeLa cells using two different NDUDA4-targeting shRNA sequences (sh.38 and sh.41). (A) Left: BNGE analysis of
digitonin-isolated mitochondria, followed by western blot with antibodies against the indicated protein. Notice that on the core 2 blot, the band for CIII + CIV is
a different exposure to better show that the supercomplex III + IV is also lost by the interference of NDUFA4. SC: supercomplexes. Right: western blots of SDS-
PAGE analysis of control and sh.41 cells. Porin was used as a loading control. (B) Western blots of 2D electrophoresis gels (BNGE followed by SDS-PAGE) of
control and sh.41 cells; membraneswere probedwith antibodies against the indicated proteins. (C) Left: BNGE analysis revealing restoration of CIV levels in sh.41
cells after exogenous overexpression of myc-tagged NDUFA4. Right: SDS-PAGE showing expression levels of myc-NDUFA4; CII was used as a loading control.
(D) CIV activity relative to citrate synthase was measured spectrophotometrically in isolated mitochondria from control cells. Error bars indicate standard
deviation of the mean. (C), NDUFA4-silenced cells (sh.38 and sh.41), and NDUFA4-silenced cells expressing myc-NDUFA4 (+NDUFA4) (E). Growth curves of
control and NDUFA4-silenced HeLa cells culture in medium containing glucose or galactose. *p < 0.05 compared with control (Student’s t test).
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lane was excised from the gel, incubated for 1 hr at room temperature
in 1% SDS and 1% b-mercaptoethanol, and run on a 16.5% second-
dimension denaturing (SDS-PAGE) gel. After electrophoresis, the com-
plexes were electroblotted onto PVDF membranes and sequentially probed
with specific antibodies against CI (anti-NDUFB6, NDUFS5, NDUFS4, and
NDUFA9), CIII (anti-core2), CIV (anti-COI), and CII (70 kDa subunit). All anti-Cell Mebodies were from Molecular Probes. NDUFA4 antibody was purchased in
Bioworld.
Protein Identification by LiquidChromatographyCoupled to Tandem
Mass Spectrometry
Gel pieces from blue native gels containing the protein bands of interest were
excised. After reduction with DTT (10 mM) and alkylation of Cys groups withtabolism 16, 378–386, September 5, 2012 ª2012 Elsevier Inc. 383
Figure 4. Sequence Evolution of NDUFA4 in Eukaryotes
(A) The analysis of NDUFA4 presence-absence patterns in fungi reveals that the NDUFA4 protein does not follow the evolutionary pattern of CI losses. Fungal
species tree (Lavı´n et al., 2008) with indicated independent losses of respiratory chain complexes is shown. The isolated CI losses do not lead to the loss of
NDUFA4, as would be expected if NDUFA4 was a CI subunit. CI, IV, and NDUFA4 presence patterns are marked in the table. Instances where CI is missing, but
NDUFA4 is preserved, are marked gray.
(B) Multiple alignment of the conserved region of NDUFA4 in eukaryotes. Species without CI are marked gray. The transmembrane region (after TMHMM [Krogh
et al., 2001]) that is common to all sequences is shown above the alignment. The alignment was prepared using Clustal-W with default parameters (Thompson
et al., 1994). Sequence identifiers are listed in Table S1.
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final mass ratio of 1:50 (trypsin-protein). Digestion proceeded overnight at
37C, after which samples were vacuum-dried and dissolved in 1% acetic
acid.
To identify proteins, the resulting tryptic peptide mixtures were analyzed by
nanoliquid chromatography coupled to mass spectrometry. Peptides were
injected onto a C-18 reversed phase (RP) nanocolumn (100 mm I.D. and
15 cm, Mediterranea Sea, Teknokroma) and analyzed on a continuous aceto-
nitrile gradient consisting of 0%–43% B for 90 min and 50%–90% B for 1 min
(B = 95% acetonitrile, 0.5% acetic acid). Peptides were eluted from the RP
nanocolumn at a flow rate of 300 nl/min to an emitter nanospray needle for
real-time ionization and peptide fragmentation on an LTQ-Orbitrap mass
spectrometer (Thermo Fisher, San Jose, CA). An enhanced FT-resolution
spectrum (resolution = 6,000) and the MS/MS spectra of the five most-intense
parent ions were analyzed during the chromatographic run (130min). Dynamic
exclusion was set at 0.5 min.384 Cell Metabolism 16, 378–386, September 5, 2012 ª2012 ElsevieFor protein identification, tandemmass spectra were extracted and charge-
state deconvoluted with Proteome Discoverer 1.2.0.207 (Thermo Fisher
Scientific). All MS/MS samples were analyzed by SEQUEST (Thermo Fisher
Scientific, version 1.0.43.2), MASCOT (Matrixscience, version 2.1) and X!
Tandem (The GPM, http://thegpm.org; version 2007.01.01.1). Search engines
were set up to search MSIPI_mouse_3.67.fasta (1.0, 56,687 entries). All
searches were performed assuming complete trypsin digestion. Two mixed
cleavages were allowed, and errors of 15 ppm or 0.8 Da were set for full MS
and MS/MS spectra searches, respectively. Oxidation of M, phosphorylation
of S or T, and deamidation of Q or N were selected as dynamic modifications.
All identifications were made by Decoy database search for FDR analysis.
Scaffold (version Scaffold_3_00_03, Proteome Software Inc., Portland, OR)
was used to validate MS/MS peptide and protein identifications. Protein
probabilities were assigned by the Protein Prophet algorithm. Proteins that
contained similar peptides and could not be differentiated based on MS/MS
analysis alone were grouped to satisfy the principles of parsimony.r Inc.
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Complexes
Mitochondrial CI or CIV was immunocaptured from isolated mitochondria
using the CI and CIV immunoprecipitation kit (Abcam) according to the manu-
facturer’s instructions.
Activities of Complex I and IV
CI and CIV activities were measured spectrophotometrically in mitochondrial
fractions (2–5 mg protein) as described (Hofhaus et al., 1996). Both activities
were expressed relative to citrate synthase activity.
Proliferation Analysis
Control, sh.38, and sh.41 HeLa cells were plated at 2 3 105 per 10 cm dish in
DMEM containing either glucose or galactose. At indicated times the cells
were trypsinized and the viable cells were counted.
Analysis of Genomic Presence-Absence Patterns
Homologs of the human NDUFA4 gene (Swissprot id: O00483) were retrieved
with three iterations of PSI-BLAST with default parameters (Altschul et al.,
1997). An alignment was build with default parameters of Clustal-W (Thomp-
son et al., 1994) and profile and a profile-based hidden Markov model
(HMM) of NDUFA4 gene were created based on the conserved part of the
multiple alignment with HMMER 3.0 (http://hmmer.org) and HHSearch 1.5
(PMID: 15531603). The HMMs ware used to retrieve homologs in eukaryotes.
Only statistically significant reciprocal-best hits highly indicative of orthology
(Szklarczyk et al., 2012) were taken into account. The absence of the gene
in B. hominis was confirmed at the genome level (by searching species’
DNA, without prior knowledge of its gene compendium) to account for possi-
bility of gene missing from B. hominis genome annotation.
Statistical Analysis
The data are presented as the means ± standard deviation of the mean of at
least three independent experiments. Statistical significance (*p < 0.05) was
assessed by Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
found with this article online at http://dx.doi.org/10.1016/j.cmet.2012.07.015.
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